INTRODUTION
Stroke is a leading cause of disability and death all over the world [1] . Recent studies have indicated that patients with chronic kidney diseases (CKD) had a higher risk for stoke and that the risk increased with decreasing glomerular filtration rate (GFR) [2] [3] [4] [5] . Reduced renal function was also proposed to be a prognostic indicator of mortality in many groups of cardiac patients [6 -10] . However, few studies investigated the impact of renal dysfunction on mortality after acute stroke. Early observation in this regard came from a study carried out to by Friedman PJ in 1991 in New Zealand. The author showed that serum creatinine is an independent predictor of mortality among 492 stroke survivals followed up for a mean period of 18 months [11] . Another early observation came from a study carried out to assess the relationship between hypertension and fatality rate in black patients with stroke [12] . The authors found that survivors significantly have lower plasma urea on admission. Subsequent studies supported these early observations. A 7-year follow-up study by MacWalter RS et. al in 2002 , indicated that patients with reduced creatinine clearance (CrCl) at admission had a higher mortality risk [13] . In 2007, Hojs Fabjan et. al indicated that in patients with ischemic stroke, decreased GFR was associated with higher risk of mortality [14] .
In line of all these studies, we carried out a one year, hospital-based study to investigate the impact of renal dysfunction on in-hospital mortality in patients with acute stroke. The results of such a study can help in developing preventive and therapeutic measures to be implemented in order to decrease the risk of in-hospital mortality among stroke patients.
METHODOLOGY
This hospital-based, one-year study was performed at Al-Watani governmental Hospital/ Nablus/ Palestine. Al-Watni hospital is a medical referral hospital that serves patients with governmental medical insurance in the north Palestine area. In this study, patients who had been admitted and diagnosed with ischemic or hemorrhagic stroke from The data for this study were obtained from the patients' medical files and included: demographic characteristics (age and sex), type of stroke (ischemic or hemorrhagic), stroke-related risk factors, and serum creatinine. Cockcroft-Gault equation was used to estimate CrCl and values for females were obtained by multiplying the result with 0.85.
Patients with CrCl < 60ml/ min were categorized as group I while patients with CrCl ≥ 60 ml/min were categorized as group II. This cut off point was used on the notion that patients with a CrCl < 60 ml/min are considered to have renal dysfunction. Risk factors considered in this study were: age (> 65 years), hypertension (HTN), ischemic heart disease (IHD), congestive heart failure (CHF), arrythmias, smoking, previous stroke and obesity. In this study, obesity was defined based on the body mass index (BMI) value, males and females with a BMI >30 were considered to be obese. The total number of stroke-related risk factors was counted for each patient and used in the analysis.
Similarly, the total number of post-stroke complications was counted for each patient and used in the analysis. Post stroke complications considered in this study were those present in the patients' medical files. The outcome of interest in this study was the vital status of the patient at discharge: dead or alive.
Statistical Analysis
Analysis of data was carried out using the "Statistical Package for Social Sciences" (SPSS) version 15.0. Data were expressed as mean +/-SD for continuous variables and as frequencies for categorical variables. Univariate analysis was carried out using independent student's t test and the Pearson Chi-square test. Statistical significance was considered at P < 0.05. Factors with P < 0.05 in the univariate analysis were entered in multiple logistic regression analysis to identify the independent predictors of inhospital mortality.
RESULTS
During the study period, 186 patients with acute stroke were admitted to AlWatani hospital. All patients were admitted within the first 24 hours of the attack and were alive upon admission. Of the 186 patients, 153 (82.26%) were diagnosed with ischemic stroke and 33 (17.74%) were diagnosed with hemorrhagic stroke. Seventy four (39.8%) of the patients had previous stroke attack while 112 (60.2%) had a first-ever stroke. Patients had an average of 3.4 ± 1.2 risk factors prior to the attack. Hypertension (n = 130, 69.9%) was the most prevalent stroke-related risk factor followed by DM (n = 84, 45.2%). The mean estimated CrCl of the study patients was 84.70 ± 48.98 ml/min, ranged from 10.93 to 203.9 ml/min. The estimated CrCl was negatively correlated with age (r= -0.503, P= 0001). There were 63 (33.9%) patients with CrCl <60ml/min (group I) while there were 123 (66.1%) patients with CrCl ≥60 ml/min (group II).
During the study period, 21% (39 patients; 25 men and 14 women) died during their hospital stay. Univariate analysis according to vital status at discharge indicated that in the total stroke patients (n = 186), the following factors were significantly associated with in-hospital mortality: gender (P = 0.033), type of stroke (P= 0.004), previous stroke (P= 0.002), CrCl (P< 0.0001), number of risk factors (P=0.001) and number of poststroke complications (P< 0.0001) ( Table 1 ). Other factors including admission systolic and diastolic blood pressure as well as the number of prior anti-hypertensive medications were insignificantly different. Multivariable logistic regression analysis showed that CrCl (P = 0.004), number of post-stroke complications (P= 0.001), and type of stroke (P = 0.034) were independent predictors of in-hospital mortality in the total stroke patients (Table 3) .
Clinical characterstics and predictots of in-hospital mortality of patients in group I and II were compared. Patients in group I have an avergae CrCl of 38.6 ± 13.3 ml/min compared to 109.1± 43 ml/min for group II. The difference was significant (P <0.0001).
Patients in group I were also significantly (P=0.001) older than those in group II (74.11± 9.46 versus 66.53± 10.74 years), had significantly higher proportion of CHF (P= 0.048) and history of previous stroke (P = 0.02). In-hospital mortality was significantly (P=0.003) different between the two groups: 33.3% in group I versus 14.6% in group II.
The characterstics of stroke patients in group I (n = 63) according to vital status at discharge are shown in table 2. Patients who died (n = 21), compared to those who were discharged alive (n = 42), had a significantly higher occurence of the following variables: hemorrhagic stroke, HTN, history of previous stroke, low CrCl level and average number of risk factors prior to the attack. Multiple logestic regression analysis indicated that the level of CrCl (P= 0.012) was the only independent predictors of in-hospital mortality in group I patients (Table 3) . However, in group II patients, CrCl was not a predictor of mortality. Patients who survived had better but insignificant difference in CrCl level than those who died. Patients who died (n = 18) had a CrCl of 98.51 ± 32.27 ml/ min while patients who were discharged alive (n = 105) had a CrCl of 110.98 ± 44.19 ml/min.
The impact of various CrCl levels on in-hospital mortality was investigated. In Figure 1 , within group mortality was plotted versus different levels of CrCl. As shown, the mortality was 14.6% in patients with CrCl > 60 ml/ min, 25% in patients with CrCl between 30 -60 ml/ min, and 60% in patients with CrCl < 30ml/ min. The nonparametric Kruskal -Wallis analysis indicated that three groups were significantly (P <0.0001) different in the frequency of in-hospital mortality but not in the number of stroke-related risk factors (P=0.94) or number of post-stroke complications (P=0.37).
Similarly, using Chi-square analysis, no significant difference was found among the three groups in the frequency of previous stroke, or stroke types. 
Table1

DISCUSSION
This study showed that CrCl calculated at admission has a significant impact on in-hospital mortality in patients with acute stroke in general and in patients with acute stroke and CrCl < 60ml/min in particular. Three indpendent predictors of mortality were identified among stroke patients in general: type of stroke, number of post stroke complications and CrCl. However, in stroke patients with renal dysfunction, CrCl was the only independent predictor of in-hospital mortality.
In our study, Patients having hemorrhagic stroke had a higher risk of mortality than those diagnosed with ischemic stroke. Similarly, other researchers had found that hemorrhagic stroke was a risk factor of mortality and poor functional outcome [15] .
Another study had also found that survival after 28 days was the lowest in patients with hemorrhagic stroke [16] . The number of post-stroke complications was also an independent predictor of in-hospital mortality in our patients. Several publications have indicated that the severity of post-stroke complications was a strong independent predictor of in-hospital mortality and long-term outcome in stroke patients. For example, one study indicated that post-stroke infection is a bad prognostic factor in stroke patients [17] . Another study indicated that post-stroke neurological complications like seizures are bad prognostic factors [18] . A study showed that mortality in ischemic stroke patients is influenced by in-hospital medical complications [19] . This finding suggests that the appropriate prevention and management of in-hospital complications could improve short-term and long-term prognosis after stroke. In our study, we believe that the number of post-stroke complications, including the neurological ones like seizure, were a reflection of the severity of stroke attack and therefore was a significant risk factor and an independent predictor of in-hospital mortality in stroke patients.
In our study, CrCl was a strong independent predictor of in-hospital mortality in stroke patients in general and in those with CrCl< 60 ml/ min in particular but not in patient with CrCl> 60ml/min. In the study by Mac Walter et al, renal function was highly significant in predicting mortality in those who died at less than 30 days compared with those who died at final follow up [13] . In the study by Fabjan et al, renal dysfunction has impact on in-hospital mortality in patients with ischemic stroke [14] . Fabjan et al also found that in patients with ischemic stroke and with exclusion of patients with normal or elevated GFR, patients who died had significantly lower GFR. In our study, CrCl in patients with ischemic stroke was significantly lower in those who died versus those who survived (data not shown) which is in agreement with Fabjan et al study. In a study by Covic et al, baseline renal function emerged as both a significant independent marker for short-term survival after an acute stroke (even after adjustment for baseline comorbidities) and as a risk factor for subsequent acute kidney injury [20] . A study found that a high serum creatinine concentration within the normal range is a marker for increased risk of cerebrovascular disease in both normotensive and hypertensive subjects [21] . The authors suggested that these findings support the evidence indicating that subtle impairment of renal function is a factor for increased risk of stroke and suggest mechanisms in the pathogenesis of stroke that warrant further investigation.
The current study as well as the previously published studies indicated that CrCl is a strong independent predictor of long term, short-term and in-hospital mortality after acute stroke. These findings should be implemented in the preventive and therapeutic strategies in patients with acute attack or those at high risk of developing stroke.
Measurement of serum creatinine and estimation of CrCl should be implemented in treatment protocol and in screening for patients at high risk of stroke. Few effective treatments are available once stroke has occurred; hence its prevention by modifying key risk factors is crucial. In a meta-analysis of four placebo-controlled trials of angiotensin converting enzyme inhibitors (ACE-I) in patients with coronary heart disease and/or diabetes mellitus, the overall risk of primary stroke was significantly reduced [22] . The HOPE trial showed that the realtive risk of stroke was significantly reduced by ramipril compared with placebo [23] , despite only a modest reduction in blood pressure (BP). The American College of Chest Physicians has issued the 8 th edition of Evidence-Based Clinical Practice Guidelines in which they recommended the use of antithrombotic and thrombolytic therapy for ischemic stroke [24] .
Finally, our study is limited in that it is a hospital-based study. Therefore, hometreated patients are excluded from the study. Those patients usually have milder forms of stroke and it would be of value to investigate the impact of CrCl on this group of patients. Furthermore, the study sample was relatively small and survivors were not followed up for a short period to compare the impact of CrCl on short term and in-hospital mortality.
Finally, although scr and CrCl are considered sensitive markers of renal function, other markers like BUN and cystatin C need to be taken into consideration [25] .
